1-6 of 6
Armelle Goubard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome

Florent Amatore, Mathilde Barré, Florence Orlanducci, Marc Lopez, Remy Castellano, Caroline Ram-Wolff, Laurent Gorvel, Armelle Goubard, Caroline Gaudy-Marqueste, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive
Journal: Blood
Blood (2021) 138 (Supplement 1): 2260.
https://doi.org/10.1182/blood-2021-153345
Published: 2021
Journal Articles

ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells

Florent Amatore, Nicolas Ortonne, Marc Lopez, Mathilde Barré, Florence Orlanducci, Remy Castellano, Saskia Ingen-Housz-Oro, Amandine De Croos, Laurent Gorvel, Armelle Goubard, Reda Bouabdallah, Jean Marc Schiano De Colella, Jean-Jacques Grob, Philippe Gaulard, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive
Journal: Blood
Blood (2021) 138 (Supplement 1): 790.
https://doi.org/10.1182/blood-2021-150677
Published: 2021
Journal Articles

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Julie Agopian, Quentin Da Costa, Quang Vo Nguyen, Giulia Scorrano, Paraskevi Kousteridou, Min Yuan, Rabie Chelbi, Armelle Goubard, Remy Castellano, Julien Maurizio, Cristina Teodosio, Paulo De Sepulveda, John M. Asara, Alberto Orfao, Olivier Hermine, Patrice Dubreuil, Fabienne Brenet
Journal: Blood
Blood (2021) 138 (17): 1590–1602.
https://doi.org/10.1182/blood.2020008948
Published: 2021
Includes: Supplemental data
Journal Articles

Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939

Martine Humbert, PhD, Armelle Goubard, PhD, Colin Mansfield, PhD, Olivier Hermine, MD PhD, Patrice Dubreuil, PhD, The AB8939 Study Group
Journal: Blood
Blood (2019) 134 (Supplement_1): 2075.
https://doi.org/10.1182/blood-2019-122540
Published: 2019
Journal Articles

In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia

Armelle Goubard, PhD, Martine Humbert, PhD, Colin Mansfield, PhD, Olivier Hermine, MD PhD, Patrice Dubreuil, PhD, The AB8939 Study Group
Journal: Blood
Blood (2019) 134 (Supplement_1): 5142.
https://doi.org/10.1182/blood-2019-127143
Published: 2019
Journal Articles

AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes

Armelle Goubard, PhD, Martine Humbert, PhD, Colin Mansfield, PhD, Olivier Hermine, MD PhD, Patrice Dubreuil, PhD, The AB8939 Study Group
Journal: Blood
Blood (2019) 134 (Supplement_1): 5154.
https://doi.org/10.1182/blood-2019-127021
Published: 2019